PubMed

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease.

Morrell NW, Higham MA, Phillips PG, Shakur BH, Robinson PJ, Beddoes RJ.

Respir Res. 2005 Aug 1;6:88.PMID: 16060962 [PubMed - indexed for MEDLINE]Related articlesFree article

Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale.

Kiely DG, Cargill RI, Wheeldon NM, Coutie WJ, Lipworth BJ.

Cardiovasc Res. 1997 Jan;33(1):201-8.PMID: 9059545 [PubMed - indexed for MEDLINE]Related articlesFree article

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

Ambrosino N, Foglio K, Balzano G, Paggiaro PL, Lessi P, Kesten S; Tiotropium Multicentric Italian Study Group.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):771-80.PMID: 19281092 [PubMed - indexed for MEDLINE]Related articlesFree article

Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.

Jaïs X, D'Armini AM, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, Hoeper MM, Lang IM, Mayer E, Pepke-Zaba J, Perchenet L, Morganti A, Simonneau G, Rubin LJ; Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group.

J Am Coll Cardiol. 2008 Dec 16;52(25):2127-34.PMID: 19095129 [PubMed - indexed for MEDLINE]Related articles

Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.

Lee TM, Chen CC, Shen HN, Chang NC.

Clin Sci (Lond). 2009 Mar;116(6):497-505.PMID: 18831711 [PubMed - indexed for MEDLINE]Related articles

Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.

Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.

Curr Med Res Opin. 2007 Feb;23(2):259-70.PMID: 17288679 [PubMed - indexed for MEDLINE]Related articles

A randomised, controlled trial of bosentan in severe COPD.

Stolz D, Rasch H, Linka A, Di Valentino M, Meyer A, Brutsche M, Tamm M.

Eur Respir J. 2008 Sep;32(3):619-28. Epub 2008 Apr 30.PMID: 18448495 [PubMed - indexed for MEDLINE]Related articlesFree article

A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.

Oparil S, Abate N, Chen E, Creager MA, Galet V, Jia G, Julius S, Lerman A, Lyle PA, Pool J, Tershakovec AM.

Curr Med Res Opin. 2008 Apr;24(4):1101-14. Epub 2008 Mar 6.PMID: 18328120 [PubMed - indexed for MEDLINE]Related articles

Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD.

Higham MA, Dawson D, Joshi J, Nihoyannopoulos P, Morrell NW.

Eur Respir J. 2001 Mar;17(3):350-5.PMID: 11405510 [PubMed - indexed for MEDLINE]Related articlesFree article

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.

Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost AE, Engel PJ, Kramer MR, Burgess G, Collings L, Cossons N, Sitbon O, Badesch DB; PACES Study Group.

Ann Intern Med. 2008 Oct 21;149(8):521-30. Erratum in: Ann Intern Med. 2009 Jan 6;150(1):63. Ann Intern Med. 2009 Sep 15;151(6):435. PMID: 18936500 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.

Galiè N, Rubin Lj, Hoeper M, Jansa P, Al-Hiti H, Meyer G, Chiossi E, Kusic-Pajic A, Simonneau G.

Lancet. 2008 Jun 21;371(9630):2093-100.PMID: 18572079 [PubMed - indexed for MEDLINE]Related articles

One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.

Parrinello G, Paterna S, Torres D, Di Pasquale P, Mezzero M, La Rocca G, Cardillo M, Trapanese C, Caradonna M, Licata G.

Clin Drug Investig. 2009;29(9):591-600. doi: 10.2165/11315250-000000000-00000.PMID: 19663521 [PubMed - indexed for MEDLINE]Related articles

A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.

Baguet JP, Nisse-Durgeat S, Mouret S, Asmar R, Mallion JM.

Int J Clin Pract. 2006 Apr;60(4):391-8.PMID: 16620350 [PubMed - indexed for MEDLINE]Related articles

Losartan with hydrochlorothiazide in the treatment of hypertension.

Schoenberger JA; Losartan Research Group.

J Hypertens Suppl. 1995 Jul;13(1):S43-7.PMID: 18800455 [PubMed - indexed for MEDLINE]Related articles

Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial).

Thomas GS, Tammelin BR, Schiffman GL, Marquez R, Rice DL, Milikien D, Mathur V.

J Nucl Cardiol. 2008 May-Jun;15(3):319-28. Epub 2008 Apr 14.PMID: 18513638 [PubMed - indexed for MEDLINE]Related articles

Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD.

Holverda S, Rietema H, Bogaard HJ, Westerhof N, Postmus PE, Boonstra A, Vonk-Noordegraaf A.

Pulm Pharmacol Ther. 2008;21(3):558-64. Epub 2008 Feb 8.PMID: 18342559 [PubMed - indexed for MEDLINE]Related articles

Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD: a preliminary study.

Kanazawa H, Hirata K, Yoshikawa J.

Thorax. 2003 Jul;58(7):629-31.PMID: 12832683 [PubMed - indexed for MEDLINE]Related articlesFree article

Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.

Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ.

Circulation. 2007 Oct 2;116(14):1555-62. Epub 2007 Sep 4.PMID: 17785618 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.

Flammer AJ, Hermann F, Wiesli P, Schwegler B, Chenevard R, Hürlimann D, Sudano I, Gay S, Neidhart M, Riesen W, Ruschitzka F, Lüscher TF, Noll G, Lehmann R.

J Hypertens. 2007 Apr;25(4):785-91.PMID: 17351370 [PubMed - indexed for MEDLINE]Related articles

Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study.

Stav D, Raz M.

Chest. 2009 Aug;136(2):381-6. Epub 2009 May 15.PMID: 19447919 [PubMed - indexed for MEDLINE]Related articles